Taoweave Financials

TWAV

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Taoweave (TWAV) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 50/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Taoweave has an operating margin of -176.7%, meaning the company retains $-177 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -118.0% the prior year.

Growth

Taoweave's revenue declined 37.6% year-over-year, from $3.8M to $2.4M. This contraction results in a growth score of 0/100.

Leverage

Taoweave carries a low D/E ratio of 0.32, meaning only $0.32 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 4.14, Taoweave holds $4.14 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Piotroski F-Score Weak

1/9

Taoweave passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Low Quality

0.84x

For every $1 of reported earnings, Taoweave generates $0.84 in operating cash flow (-$3.4M OCF vs -$4.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Revenue

$2.4M

YoY-37.6%

5Y CAGR-28.6%

10Y CAGR-22.9%

Taoweave generated $2.4M in revenue in fiscal year 2024. This represents a decrease of 37.6% from the prior year.

EBITDA

-$4.2M

YoY-1.3%

Taoweave's EBITDA was -$4.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1.3% from the prior year.

Free Cash Flow

N/A

Net Income

-$4.0M

YoY+7.8%

Taoweave reported -$4.0M in net income in fiscal year 2024. This represents an increase of 7.8% from the prior year.

EPS (Diluted)

N/A

Cash & Debt

$5.0M

YoY-17.1%

5Y CAGR+1.5%

10Y CAGR+9.9%

Taoweave held $5.0M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

YoY+99.6%

Taoweave had 1M shares outstanding in fiscal year 2024. This represents an increase of 99.6% from the prior year.

Gross Margin

13.9%

YoY-10.0pp

5Y CAGR-28.2pp

Taoweave's gross margin was 13.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 10.0 percentage points from the prior year.

Operating Margin

-176.7%

YoY-58.7pp

5Y CAGR-117.6pp

10Y CAGR-173.0pp

Taoweave's operating margin was -176.7% in fiscal year 2024, reflecting core business profitability. This is down 58.7 percentage points from the prior year.

Net Margin

-170.0%

YoY-54.9pp

5Y CAGR-109.5pp

10Y CAGR-161.5pp

Taoweave's net profit margin was -170.0% in fiscal year 2024, showing the share of revenue converted to profit. This is down 54.9 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

$155K

YoY+675.0%

5Y CAGR-40.2%

Taoweave invested $155K in research and development in fiscal year 2024. This represents an increase of 675.0% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

TWAV Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$2.4M-37.6%	$3.8M-30.4%	$5.5M-29.2%	$7.7M-49.5%	$15.3M+19.5%	$12.8M
Cost of Revenue	$2.0M-29.4%	$2.9M-26.2%	$3.9M-21.7%	$5.0M-31.0%	$7.3M-2.0%	$7.4M
Gross Profit	$331K-63.7%	$911K-41.1%	$1.5M-43.1%	$2.7M-66.2%	$8.1M+49.1%	$5.4M
R&D Expenses	$155K+675.0%	$20K-98.8%	$1.7M-41.7%	$2.9M-21.5%	$3.7M+83.4%	$2.0M
SG&A Expenses	$4.2M-13.8%	$4.9M-7.7%	$5.3M-17.1%	$6.4M-5.4%	$6.7M+25.1%	$5.4M
Operating Income	-$4.2M+6.5%	-$4.5M+79.6%	-$22.0M-86.4%	-$11.8M-17.2%	-$10.1M-32.9%	-$7.6M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$10K-63.0%	$27K+485.7%	-$7K+92.2%	-$90K-187.4%	$103K	$0
Net Income	-$4.0M+7.8%	-$4.4M+80.0%	-$21.9M-142.4%	-$9.1M-22.0%	-$7.4M+4.4%	-$7.8M
EPS (Diluted)	N/A	$-0.98	$-10.62-93.8%	$-5.48	$-1.48	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	$601K+1.5%	$592K-4.8%	$622K+10.5%	$563K-2.6%	$578K-5.4%	$611K-2.4%	$626K-33.7%	$944K
Cost of Revenue	$357K-1.9%	$364K-2.4%	$373K-12.9%	$428K-14.2%	$499K+1.6%	$491K-21.9%	$629K-4.0%	$655K
Gross Profit	$244K+7.0%	$228K-8.4%	$249K+84.4%	$135K+70.9%	$79K-34.2%	$120K+4100.0%	-$3K-101.0%	$289K
R&D Expenses	$3K0.0%	$3K0.0%	$3K+50.0%	$2K-94.7%	$38K-41.5%	$65K+30.0%	$50K+1150.0%	$4K
SG&A Expenses	$1.0M+15.6%	$902K-2.9%	$929K-12.1%	$1.1M+1.0%	$1.0M+3.1%	$1.0M-5.7%	$1.1M-6.1%	$1.1M
Operating Income	-$802K-17.4%	-$683K+1.2%	-$691K+25.5%	-$928K+13.4%	-$1.1M-5.3%	-$1.0M+14.0%	-$1.2M+7.2%	-$1.3M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$0	$0-100.0%	$7K+600.0%	$1K	$0-100.0%	$9K	$0+100.0%	-$11K
Net Income	-$2.3M-278.5%	-$605K+10.0%	-$672K+24.0%	-$884K+15.0%	-$1.0M-5.8%	-$983K+13.5%	-$1.1M+7.0%	-$1.2M
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	$-0.07	N/A

TWAV Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$5.3M-23.8%	$6.9M+22.3%	$5.7M-80.2%	$28.6M-1.8%	$29.1M-16.5%	$34.9M
Current Assets	$5.3M-23.6%	$6.9M+41.5%	$4.9M-61.8%	$12.8M+27.6%	$10.0M+0.7%	$9.9M
Cash & Equivalents	$5.0M-17.1%	$6.0M+94.2%	$3.1M-65.7%	$9.0M+70.6%	$5.3M+14.7%	$4.6M
Inventory	$0-100.0%	$239K-66.9%	$723K-60.3%	$1.8M+97.9%	$920K-49.3%	$1.8M
Accounts Receivable	$186K-56.1%	$424K+2.2%	$415K-51.1%	$849K-73.2%	$3.2M+24.5%	$2.5M
Goodwill	$0	$0	$0-100.0%	$7.4M0.0%	$7.4M-6.8%	$7.9M
Total Liabilities	$1.3M-10.7%	$1.4M-30.3%	$2.0M-34.3%	$3.1M-56.1%	$7.1M-46.0%	$13.1M
Current Liabilities	$1.3M-9.0%	$1.4M-26.9%	$1.9M-23.3%	$2.5M-55.3%	$5.6M-32.5%	$8.3M
Long-Term Debt	N/A	N/A	N/A	$0-100.0%	$403K-85.8%	$2.8M
Total Equity	$4.0M-27.2%	$5.5M+52.0%	$3.6M-85.8%	$25.5M+15.6%	$22.1M+1.2%	$21.8M
Retained Earnings	-$232.3M-1.8%	-$228.2M-2.0%	-$223.8M-10.9%	-$201.9M-4.7%	-$192.9M-4.0%	-$185.4M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$10.9M-16.6%	$13.1M+174.7%	$4.8M-9.9%	$5.3M-12.0%	$6.0M-4.9%	$6.3M+6.2%	$5.9M-14.3%	$6.9M
Current Assets	$10.9M-16.6%	$13.1M+174.9%	$4.8M-9.9%	$5.3M-12.0%	$6.0M-4.9%	$6.3M+6.3%	$5.9M-14.1%	$6.9M
Cash & Equivalents	$3.7M-65.4%	$10.8M+150.1%	$4.3M-13.1%	$5.0M-11.6%	$5.6M-4.1%	$5.9M+9.3%	$5.4M-10.5%	$6.0M
Inventory	N/A	N/A	N/A	$0-100.0%	$50K-43.2%	$88K-30.7%	$127K-46.9%	$239K
Accounts Receivable	$12K-20.0%	$15K-86.7%	$113K-39.2%	$186K+463.6%	$33K+6.5%	$31K+106.7%	$15K-96.5%	$424K
Goodwill	N/A	N/A	N/A	$0	N/A	N/A	N/A	$0
Total Liabilities	$1.1M-40.9%	$1.8M+29.0%	$1.4M+10.5%	$1.3M-3.8%	$1.3M+5.5%	$1.3M-16.5%	$1.5M+5.4%	$1.4M
Current Liabilities	$1.1M-40.9%	$1.8M+29.0%	$1.4M+10.5%	$1.3M-3.6%	$1.3M+5.9%	$1.2M-16.1%	$1.5M+6.4%	$1.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$9.8M-12.7%	$11.3M+235.9%	$3.4M-16.3%	$4.0M-14.3%	$4.7M-7.5%	$5.1M+13.9%	$4.4M-19.4%	$5.5M
Retained Earnings	-$235.8M-1.0%	-$233.6M-0.3%	-$232.9M-0.3%	-$232.3M-0.4%	-$231.4M-0.5%	-$230.3M-0.4%	-$229.4M-0.5%	-$228.2M

TWAV Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$3.4M-13.8%	-$3.0M+49.6%	-$5.9M+23.3%	-$7.7M-17.8%	-$6.6M-101.8%	-$3.3M
Capital Expenditures	N/A	$0-100.0%	$11K-78.0%	$50K+31.6%	$38K-15.6%	$45K
Free Cash Flow	N/A	-$3.0M+49.7%	-$5.9M+23.6%	-$7.8M-17.8%	-$6.6M-100.2%	-$3.3M
Investing Cash Flow	$0	$0-100.0%	$19K+138.8%	-$49K-58.1%	-$31K-101.4%	$2.1M
Financing Cash Flow	$2.4M-59.6%	$5.9M	$0-100.0%	$11.5M+58.2%	$7.3M+96.6%	$3.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	$0-100.0%	$51K

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	-$1.6M-4100.0%	-$37K+94.6%	-$680K+23.2%	-$885K+2.8%	-$911K+7.0%	-$980K-55.6%	-$630K+10.6%	-$705K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$705K
Investing Cash Flow	-$6.3M	N/A	N/A	$0	$0	N/A	N/A	$0
Financing Cash Flow	$846K-89.6%	$8.2M+26241.9%	$31K-86.6%	$231K-65.6%	$672K-54.5%	$1.5M	$0+100.0%	-$71K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

TWAV Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	13.9%-10.0pp	23.9%-4.3pp	28.2%-6.9pp	35.1%-17.4pp	52.5%+10.4pp	42.1%
Operating Margin	-176.7%-58.7pp	-118.0%+283.5pp	-401.5%-249.1pp	-152.4%-86.8pp	-65.6%-6.6pp	-59.1%
Net Margin	-170.0%-54.9pp	-115.1%+285.6pp	-400.7%-283.7pp	-117.0%-68.5pp	-48.4%+12.1pp	-60.5%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-76.6%-13.3pp	-63.3%+324.3pp	-387.6%-355.9pp	-31.6%-6.2pp	-25.5%-3.2pp	-22.2%
Current Ratio	4.14-0.8	4.93+2.4	2.55-2.6	5.11+3.3	1.79+0.6	1.20
Debt-to-Equity	0.32+0.1	0.26-0.3	0.56+0.6	0.00-0.0	0.02-0.1	0.13
FCF Margin	N/A	-78.6%+30.0pp	-108.6%-8.0pp	-100.6%-57.5pp	-43.1%-17.4pp	-25.7%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	40.6%+2.1pp	38.5%-1.5pp	40.0%+16.0pp	24.0%+10.3pp	13.7%-6.0pp	19.6%+20.1pp	-0.5%-31.1pp	30.6%
Operating Margin	-133.4%-18.1pp	-115.4%-4.3pp	-111.1%+53.7pp	-164.8%+20.6pp	-185.5%-18.9pp	-166.6%+22.5pp	-189.1%-54.0pp	-135.2%
Net Margin	-381.0%-278.8pp	-102.2%+5.8pp	-108.0%+49.0pp	-157.0%+22.9pp	-179.9%-19.0pp	-160.9%+20.6pp	-181.5%-52.1pp	-129.3%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-21.0%-16.4pp	-4.6%+9.5pp	-14.1%+2.6pp	-16.8%+0.6pp	-17.3%-1.8pp	-15.6%+3.5pp	-19.1%-1.5pp	-17.6%
Current Ratio	10.18+3.0	7.21+3.8	3.38-0.8	4.14-0.4	4.53-0.5	5.05+1.1	3.98-0.9	4.93
Debt-to-Equity	0.11-0.1	0.16-0.3	0.42+0.1	0.32+0.0	0.28+0.0	0.25-0.1	0.34+0.1	0.26
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-74.7%

Frequently Asked Questions

What is Taoweave's annual revenue?

Taoweave (TWAV) reported $2.4M in total revenue for fiscal year 2024. This represents a -37.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Taoweave's revenue growing?

Taoweave (TWAV) revenue declined by 37.6% year-over-year, from $3.8M to $2.4M in fiscal year 2024.

Is Taoweave profitable?

No, Taoweave (TWAV) reported a net income of -$4.0M in fiscal year 2024, with a net profit margin of -170.0%.

What is Taoweave's EBITDA?

Taoweave (TWAV) had EBITDA of -$4.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Taoweave's gross margin?

Taoweave (TWAV) had a gross margin of 13.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Taoweave's operating margin?

Taoweave (TWAV) had an operating margin of -176.7% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Taoweave's net profit margin?

Taoweave (TWAV) had a net profit margin of -170.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Taoweave's operating cash flow?

Taoweave (TWAV) generated -$3.4M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Taoweave's total assets?

Taoweave (TWAV) had $5.3M in total assets as of fiscal year 2024, including both current and long-term assets.

How much does Taoweave spend on research and development?

Taoweave (TWAV) invested $155K in research and development during fiscal year 2024.

How many shares does Taoweave have outstanding?

Taoweave (TWAV) had 1M shares outstanding as of fiscal year 2024.

What is Taoweave's current ratio?

Taoweave (TWAV) had a current ratio of 4.14 as of fiscal year 2024, which is generally considered healthy.

What is Taoweave's debt-to-equity ratio?

Taoweave (TWAV) had a debt-to-equity ratio of 0.32 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Taoweave's return on assets (ROA)?

Taoweave (TWAV) had a return on assets of -76.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Taoweave's cash runway?

Based on fiscal year 2024 data, Taoweave (TWAV) had $5.0M in cash against an annual operating cash burn of $3.4M. This gives an estimated cash runway of approximately 17 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Taoweave's Piotroski F-Score?

Taoweave (TWAV) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Taoweave's earnings high quality?

Taoweave (TWAV) has an earnings quality ratio of 0.84x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Taoweave?

Taoweave (TWAV) scores 50 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.